Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Compound 7p shows strong potential as an anticancer agent.

JAK inhibitors are effective treatments for alopecia areata.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib may effectively treat lichen planopilaris.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.